Neos Therapeutics, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015
Net product sales
Revenues:
Net product sales
Cost of goods sold
Gross profit
Research and development expenses
Selling and marketing expenses
General and administrative expenses
Loss from operations
Interest expense
Loss on debt extinguishment
Other income, net
Change in fair value of earnout and warrant liabilities
Net loss from continuing operations
Loss before income taxes
Income tax expense (benefit)
Net loss
Preferred stock accretion to redemption value
Preferred stock dividends
Net loss from continuing operations attributable to common stock
Net loss attributable to common stock
Weighted average common shares outstanding used to compute net loss per share, basic and diluted
Net loss per share from continuing operations attributable to common stock
Net loss per share of common stock, basic and diluted

Comments